DE IDENTIFIED HEALTH DATA MARKET Size and trends

De-identified Health Data Market, By Type of Data (Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Claims Data, Behavioral Data, Wearable and Sensor Data, Survey and Patient-Reported Data, Imaging Data , Laboratory Data, Social Determinants of Health (SDOH) Data, and Others), By Application (Clinical Research and Trials, Public Health, Precision Medicine, Health Economics and Outcomes Research (HEOR), Population Health Management, Drug Discovery and Development, Healthcare Quality Improvement, Insurance Underwriting and Risk Assessment, and Others), By End User (Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies/Healthcare Payers, Research Institutions, Government Agencies, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI7476
Pages :135
Formats :
Excel and PDF
Industry : Healthcare IT

De Identified Health Data Market Size and Trends

De-identified health data market is estimated to be valued at USD 8.21 Bn in 2025 and is expected to reach USD 15.31 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032. With increasing focus on data privacy and availability of large amounts of healthcare data, de-identified health data market is expected to witness rapid growth in the near future.

De-identified Health Data Market Key Factors

To learn more about this report, Request sample copy

Rising demand for real-world evidence and integration of analytics in healthcare are also driving the market growth. Furthermore, increasing investments by pharmaceutical and medical devices companies in digital healthcare will boost the need for anonymized healthcare databases.

DE IDENTIFIED HEALTH DATA MARKET Size and trends

De Identified Health Data Market Size and Trends

De Identified Health Data Market Report Snapshots

EXISTING CLIENTELE